期刊文献+

万古霉素不同给药方式对血清蛋白代谢的影响

The Influnce of Vancomycin on Serum Proteins by Two Different Administration
下载PDF
导出
摘要 目的:探讨万古霉素不同给药方式对血清蛋白代谢的影响。方法:回顾性分析ICU既往收治MRSA感染患者96例,在我科开展PK/PD模型引导抗生素治疗方案之前按照常规给予万古霉素治疗52例及按照PK/PD模型引导给药44例,比较两组治疗后尿微量蛋白阳性率差异。结果:PK/PD治疗组患者尿微量蛋白阳性率明显低于常规给药组。结论:PK/PD模型引导万古霉素治疗优化方案可以明显减轻患者肾损害,维持血清蛋白代谢的稳定。 Objective :To discuss the influence of Vancomycin on serum proteins by two different administration .Meth‐ods:A total of 96 patients infected with MRSA administrated Vancomycin by two different ways ,the conventional way and the PK/PD modeling guiding way .Then compare positive rate of urinary microproteins of two groups .Results:The positive rate of urinary microproteins of group conventional way was significantly higher than that of group PK /PD Modeling Guiding way .Conclusion:Application of Vancomycin by PK/PD Modeling Guidingway can significantly re‐duce renal damage and Maintain concentration of serum proteins stable .
出处 《医学理论与实践》 2015年第7期844-845,共2页 The Journal of Medical Theory and Practice
基金 莱芜市科技局专项科研立项项目(20120318)
关键词 万古霉素 血清蛋白 尿微量蛋白 PK/PD模型引导 Vancomycin PK/PD Modeling Guiding Serum proteins Urinary microproteins
  • 相关文献

参考文献6

  • 1万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561-573. 被引量:610
  • 2李瑾,殷少军,李微,陈维杰,张毅琴,陆卫东,沈瑾,董福轮.血清胱抑素C、尿微量蛋白联合检测在万古霉素致早期肾损害中的应用[J].实用药物与临床,2012,15(5):276-278. 被引量:11
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 4Klevens RM,Morrison MA,Nadle J,et al.Invasive methicillin-resistant Staphylo-coccus aureus infections in the United States[J].JAMA,2007,298(15):1763-1771.
  • 5Rybak MJ,Lomaestro BM,Rotscahfer JC,et al.Vancomycin Therapeutic Guide-lines:A Summary of Consensus Recommendations from the Infectious Diseases Society of America,the American Society of Health-System Pharmacists,and the Society of Infectious Diseases Pharmacists[J].Clin Infect Dis,2009,49(3):325-327.
  • 6Howden BP,Davies JK,Johnson PD,et al.Reduced vancomycin susceptibility in Staphylococcus aureus,including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains:resistance mechanisms,laboratory detection,and clinical implications[J].Clin Microbiol Rev,2010,23(1):99-139.

二级参考文献30

  • 1刘杨,吴菊芳,萧正伦,盛瑞媛,吕晓菊,陈燕,张婴元.1031例患者应用去甲万古霉素不良反应观察[J].中华内科杂志,2004,43(11):815-819. 被引量:46
  • 2张峰,贾金海.大剂量阿糖胞苷与甲氨蝶呤化疗对肾损害的探讨[J].中国医药,2006,1(2):87-88. 被引量:6
  • 3Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 4Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
  • 5Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
  • 6Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
  • 7Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
  • 8Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
  • 9Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25.
  • 10Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature[J]. Clin Infent Dis, 2009,49(2):271-274.

共引文献1012

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部